FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Safety Alert on Hintermann Ankle Replacement

FDA issues safety alert on a higher-than-expected risk of device failure with DT MedTechs Hintermann Series H3 Total Ankle Replacement system.

Medical Devices

Proposed Wound Product Rule Draws Fire

Three stakeholder organizations raise many questions about and objections to an FDA proposed rule on wound products.

latest-news-card-1
Human Drugs

Fake Weight Loss Drugs Concern Califf

FDA commissioner Robert Califf expresses concern about fake and compounded weight-loss drugs and the disparity in the availability of branded weight-l...

latest-news-card-1
Medical Devices

FDA Clears Nevro Sacroiliac Joint Fusion Device

FDA clears a Nevro 510(k) for its Nevro1 sacroiliac joint fusion device for treating chronic SI joint pain.

latest-news-card-1
Medical Devices

Medtronic Recalls Cerebrospinal Fluid Drain

Medtronic Neurology recalls its Duet External Drainage and Monitoring System, which is used to drain cerebrospinal fluid (CSF) to reduce intracranial ...

latest-news-card-1
Human Drugs

U.S. Generally Fastest in New Drug Launches

An HHS-funded RAND study finds that many new drugs are available in the U.S. before launching in other countries.

latest-news-card-1
Federal Register

Baxter Debarment Reduced by 3 Years

Federal Register notice: FDA issues an order to reduce a five-year debarment against former Indivior global medical director Timothy Baxter.

latest-news-card-1
FDA General

Supreme Court Could Hit FDA Regulation: FDLI

A detailed FDLI analysis looks at how expected Supreme Court changes to the Chevron federal agency deference principle will likely affect FDA and regu...

latest-news-card-1
Human Drugs

Priority Review Granted for Galactosemia NDA

FDA accepts for priority review an Applied Therapeutics NDA for AT-007 (govorestat) for treating classic Galactosemia.

latest-news-card-1
Biologics

Marks Sees Breakout Year in Gene Therapy Approvals

CBER director Peter Marks says he expects 2024 to be a big year for gene therapy approvals as several Center initiatives take hold to advance product ...